Teladoc Health (TDOC)Chief Accounting Officer sold ~$3.7K

~$3.7K

Approx. value · 655 sh @ $5.65

14K

Holds after · shares reported

Traded

Oct 2, 2026

Filed

Oct 6, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 3, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Effective August 3, 2026, the Board of Directors (the “Board”) of Teladoc Health, Inc. (the “Company”) increased the number of directors on the Board to ten and appointed Mark V. Anquillare as a director of the Company.”
2. Aug 10, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On August 10, 2026, Mr. David B. Snow, Jr. notified Teladoc Health, Inc. (the “Company”) of his intention to retire from the Board effective as of September 30, 2026.”
3. Aug 27, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Effective August 31, 2026, Teladoc Health, Inc. (the “Company”) hired Michael Grasher as its Chief Financial Officer. Charles Divita, III, who served as the Company’s interim principal financial officer, will continue as Chief Executive Officer.”
4. Sep 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On September 24, 2026, Mr. Adam C. Vandervoort, Chief Legal Officer and Secretary of Teladoc Health, Inc. (the "Company"), informed the Company of his decision to resign, effective November 1, 2026.”
5. Oct 2, 2026 · this disclosureInsiderOfficer sold ~$3.7K of TDOC shares in the open market

What came next

1. Oct 8, 20265% stakeDimensional Fund Advisors LP reported a passive stake (13G) of 5.0%

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Teladoc Health

For Teladoc Health, OQRO holds 1 insider filing (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TDOC page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Teladoc Health

• SEC Form 13F-HRMay 15, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 13F-HRNov 13, 2025
• SEC Form 4Sep 11, 2025
• SEC Form 4Sep 3, 2025

Everything OQRO holds on this company is on its TDOC page.